JPRN-UMIN000011794已完成未知
PhaseII trial of Gemcitabine(G)and Platinam-doublet plus continuous maintenance Gemcitabine in untreated stage three/four squamous non-small cell lung cancer(NSCLC) - PhaseII trial of Gemcitabine(G)and Platinam-doublet plus continuous maintenance Gemcitabine in untreated stage three/four squamous non-small cell lung cancer(NSCLC)
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patient having clear infection (2) Patient having hepatitis B with the activity (3) Serious complications (stroma-related pneumonia, bleeding tendency, control are poor a heart trouble, pulmonary fibrosis) The patient whom high blood pressure or diabetes have) (4) Patient having an active overlap cancer (under nondisease period five years) (5) Metastasis to brain patient having a symptom (6) Hydrothorax to need treatment, abdominal dropsy retention patient (7) Pericardial fluid retention patient (8) Patient having an anamnesis of drug allergies (9) A pregnant woman, a nursing girl and woman with the possibility (intention) of the pregnancy (10) principal investigator cases that are deemed inappropriate
研究者
相似试验
招募中
2 期
Biliary tract cancer cross-over studybiliary tract cancerJPRN-jRCT1041230014Yamashita Tatsuya50
进行中（未招募）
1 期
_Metastatic collecting duct carcinomaMedDRA version: 17.1 Level: LLT Classification code 10073252 Term: Carcinoma of the collecting ducts of Bellini System Organ Class: 100000004864EUCTR2013-001179-19-FRICANCER41
已完成
不适用
Phase II trial of gemcitabine and cisplatin in patients with completely resected stage IB-IIIA non-small-cell lung cancer.JPRN-UMIN000000705First Department of Surgery Hamamatsu University School of Medicine20
已完成
不适用
A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urotheliumCancerISRCTN88259320School of Medicine, Zhejiang University (China)39
尚未招募
2 期
A phase 2 trial of GN (gemcitabine + nedaplatin) therapy for advanced urothelial cancer patients with pre-treatment of cisplatin or carboplatin.urothelial cancerJPRN-UMIN000021298Yamagata University, Department of Urology62